Anyway the MSO "holy trinity" of Cresco GTI and CURA will have earnings in March so it might be something worth watching. It's all at the mercy of the broad market though in the end.
Anyway the MSO "holy trinity" of Cresco GTI and CURA will have earnings in March so it might be something worth watching. It's all at the mercy of the broad market though in the end.
Yeah it's a horse shit sector with very few catalysts upcoming. I've definitely gone a lot lighter than I have in the past and no longer holding long. Buying GTII in the 10's and selling in the 12's/13's has basically been my main play since I got back into pot stocks in August of last year. The only things keeping me from bailing entirely is 1. I have a strong read on these names. I've spent a lot of time playing them so I feel comfortable in my reads. I've done very well despite the downtrend.. If we ever get a run going things should be able to fly like the old days. Until bulls prove otherwise, I'm fading the pops though.VLNS had killer earnings, smart management team but got swept up in the massive selling. Held my nose and bought more at a 33% discount.
I don't want to lose my patience with pot, but I'm getting close. The lack of institutional support makes them trade like ass.
Just when retail investors got back into the market in full force swapping stock tips.
Morgan Stanley marked a short term top, buying E-Trade (5 million customers) just last week. Can't make this shit up.
Yes I saw that. Read the reports.. It's basically the only analysis I've seen that is neutral on CURA and GTII. PT's were quite high though, especially relative to today. TRUL is a slam dunk. I have some of them too. Profitable, growing at a ridiculous rate and cashed up. Explosive potential.Not that it's gospel, but I was reading the Cantor Fitzgerald coverage reports issued last week.
They are neutral on CURA, GTII
Overweight on TRUL, Cresco
USDTheir price target for CURA is just 8.60. Stock is over 7 today.
That was a weird one for me. I have the exact opposite take. They're a bit too cautious.. which paid off during the capital crunch (that kind of took down harv seems to have worked for Cura), but I feel it may limit their upside when compared to Cresco or Cura. Their strategy is basically to penetrate a select few markets and become leaders as opposed to Curaleaf who are every fucking where. They have a huge presence in Illinois which is pretty damn important at this stage.. that's where there growth will come from in the short term.I think they were tepid on GTII because they deemed them "overextended"...which feels like a nice way of saying they don't trust management to deliver the goods in all their makerts
I mean their market cap right now is under 1 billion I believe. They're going to probably do 500 million in 2020 and be profitable. Yeah.... It's aggressive but if stocks made sense and market caps made sense... In a MJ bull their target is not completely insane.Thanks man. That makes sense. So, their price target for TRUL ($30 US, $40 CDN) is super aggressive considering the stock is currently trading at less than a third of that target.
But ultimate these fucking stocks need to get on a real exchange. There's a half decent chance it happens in the next couple years at least
Yeah that shit isn't happening till 2021 which is ridiculous. A dem win would do some good but anyone that believes Bernie can legalize federally is dreaming. Best case for MJ this year is hype from a Bernie run and maybe some polls showing him ahead of trump and whatnot.the f ucking SAFE act has become even more complicated than anticipated
Chop chop chop chop